Skip to main content
PolicySpeak
← All files
EL

Edwards Lifesciences

Company · Switzerland · EU Transparency Register 908457634413-95

5
positions filed
in the 326 files tracked
5
legislative files
of 326 tracked
5
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #144 by legislative files engaged — a count of participation, not a measure of influence.

1.2
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
2
EP accreditations
as declared to the register
2019
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Head office
Dilbeek, Belgium

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Edwards in PolicySpeak: request access →

Work at Edwards Lifesciences? so we know who speaks for it.

Follow the files Edwards Lifesciences engages with

One email on Tuesdays when a new position is filed on these 5 files, from Edwards Lifesciences or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Edwards Lifesciences filed 5 positions between 6 Mar 2025 and 19 May 2026, across 5 of the 326 legislative files tracked here, attaching a full position paper 5 times.

2025 · 3 filed2026 · 2 filed

What they argued

Evaluation of the Public Procurement Directivesfiled 6 Mar 2025PDFsource

As a global leader in structural heart diseases, Edwards Lifesciences strongly supports the objectives of the EU Public Procurement Directive to improve quality access to healthcare technologies. After more than 10 years of application, and many challenges in its rightful execution, the revision of the EU Directive on Public Procurement provides an important opportunity to ensure that breakthrough implantable…

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025PDFsource

Edwards Lifesciences, a global leader in breakthrough structural heart innovations investing 19% of annual revenues in breakthrough research & innovation, strongly welcomes the upcoming reform of the EU Medical Device Regulation process.

Revision of EU rules on public procurementfiled 26 Jan 2026PDFsource

As a global leader in structural heart diseases, Edwards Lifesciences strongly supports the objectives of the EU Public Procurement Directive to improve quality access to healthcare technologies. After more than 10 years of application, and many challenges in its rightful execution, the revision of the EU Directive on Public Procurement provides an important opportunity to ensure that breakthrough implantable…

European Innovation Actfiled 3 Oct 2025PDFsource

Edwards Lifesciences welcomes the proposal for the European Innovation Act as a timely and strategic initiative to accelerate the uptake of breakthrough innovation and strengthen Europes industrial competitiveness.

Health Checks for Cardiovascular diseasesfiled 19 May 2026PDFsource

The recently adopted European Union Cardiovascular Health Safe Hearts Plan represents a critical step forward to tackle the burden of Europes leading cause of death, cardiovascular disease (CVD), including Structural Heart Disease (SHD).

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 198.

Is this your organization?

Everything on this page comes from Edwards Lifesciences’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.